Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Evaporative Dry Eye Disease
Interventions
DEVICE

I-DROP MGD

All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30

DEVICE

Theloze Duo

All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30

DEVICE

Systane Complete PF

All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30

Sponsors

Lead Sponsor

All Listed Sponsors
lead

I-MED Pharma

INDUSTRY